期刊文献+

普拉格雷的合成 被引量:4

Synthesis of Prasugrel
原文传递
导出
摘要 邻氟苯乙酸乙酯经溴化得2-溴-2-邻氟苯基乙酸乙酯(2),2与2-(叔丁基二甲基硅氧基)-4,5,6,7-四氢噻吩并[3,2-c]吡啶(3)缩合再经格氏反应制得2-(叔丁基二甲基硅氧基)-5-(α-环丙羰基-2-氟苄基)-4,5,6,7-四氢噻吩并[3,2-c]-吡啶(5),5经脱保护和乙酰化得普拉格雷,总收率48%(以3计)。 Prasugrel was synthesized from ethyl 2- (2-fluorophenyl) acetate by bromination, condensation with 2- [ (tert-butyldimethylsilyl) oxy] -4,5,6,7-tetrahydrothieno E3,2-c]pyridine (3) and Grignard reaction to give 2- [ (tert- butyldimethylsilyl) oxy] -5- (α-cyclopropylcarbonyl-2-fluorobenzyl) -4,5,6,7-tetrahydrothieno [3,2-c] pyridine (5), which was subjected to deprotection and acetylation with an overall yield of 48 % (based on compound 3).
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2014年第10期913-916,共4页 Chinese Journal of Pharmaceuticals
基金 教育部创新团队发展计划 辽宁省高校创新团队的支持资助
关键词 普拉格雷 抗凝血药 合成 prasugrel anticoagulant drug synthesis
  • 相关文献

参考文献10

  • 1Calatzis A.Another view on prasugrel [J].Thromb Haemost,2009,101(1): 12-13.
  • 2Scott DM,Norwood RM,Parra D.P2Y12 inhibitors in cardiovascular disease: focus on prasugrel [ J] .Ann Pharmacother,2009,43(1): 64-76.
  • 3李素义,梁艳霞,陈国华.盐酸普拉格雷合成路线图解[J].中国医药工业杂志,2010,41(11):869-872. 被引量:8
  • 4Koike H,Asai F,Sugidachi A,et al.Tetrahydrothienopyridine derivatives,furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation: US,5288726 [P].1994-02-22.
  • 5孙志国,侯建,邹强,王国平,张越.普拉格雷的合成[J].中国医药工业杂志,2009,40(4):244-246. 被引量:16
  • 6竺伟,陈宇.普拉格雷的合成[J].中国医药工业杂志,2012,43(8):647-649. 被引量:4
  • 7Mezei T,Lukacs G,Molnar E,et al.Process for the preparation of pharmaceutical intermediates: WO,2009068924 [P].2010-06-24.
  • 8Erfinder A,Dietz J,Grote T,et al.Preparation of imidazoles and triazoles as agrochemical fungicides: WO,2010031848[P].2010-05-25.
  • 9Pan XH,Rui H,Zhang JS,et al.Efficient synthesis of prasugrel,a novel P2Y12 receptor inhibitor [J].Tetrahedron Lett,2012,53(40): 5364-5366.
  • 10何昆仑,周敦峰,雷江,等.普拉格雷中间体及其制备方法:中国,101735241[P].2010-06-16.

二级参考文献30

  • 1Jakubowski JA, Winters KJ, Naganuma H, et al. Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile [J]. Cardiovascular Drug Rev, 2007, 25 (4) : 357-374.
  • 2Alain B, Daniel F, Jean-Pierre M, et al. Derivatives of alpha- (2-oxo-2,4,5,6,7,7a-hexahydrothieno [3,2-c]-5- pyridyl)phenyl acetic acid, and their use as platelet and thrombotic aggregation inhibitiors: US, 4740510 [P]. 1988-04-26. (CA 1986, 107: 89900)
  • 3Hiroyuki K, Fumitoshi A, Atsuhiro S, et al. Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation: EP, 0542411 [P]. 1993-05-19. (CA 1993, 120: 8583)
  • 4赵志全,白文钦.氢化吡啶衍生物及其盐的制备方法:中国,101177430[P].2007-12-11.
  • 5Walsh S. FDA approves Effient to reduce the risk of heart attack in angioplasty patients [EB/OL]. [2009-07-10]. http:// www.fda.gov/NewsEvents/N ucm 171497.htm cements/.
  • 6Badorc A, Frehel D, Maffrand JP, et al. Derivatives of α- (2-oxo-2,4,5,6,7,7a-hexahydro thieno [3,2-c] -5-pyridyl) phenyl acetic acid, and their use as platelet and thrombotic aggregation inhibitors: US, 4740510 [P]. 1988-04-26. (CA 1986, 107: 89900).
  • 7Satyanarayana Reddy M, Eswaraiah S, Venkat Reddy G. Improved process for the preparation of prasugrel and its pharmaceutically acceptable salts: WO, 2009066326 [P]. 2009-05-28. (CA 2009, 150: 563807).
  • 8Padi PR, Peri SRS, Ganta MR, et al. Process for the preparation of prasugrel, and its salts and polymorphs: WO, 2009062044 [P]. 2009-05-14. (CA 2009, 150: 539696).
  • 9孙志国.普拉格雷及其类似物的合成研究[C].河北科技大学硕士论文,2003.
  • 10Hana S, Josef H, Michal D, et al. A method for the manufacture of highly pure prasugrel: WO, 2010060389 [P]. 2010-06-03. (CA2010, 153: 11640).

共引文献17

同被引文献23

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部